StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed total assets

Total assets on the balance sheet at the end of each period.

MariMed's total assets was $198.31M at Sep 30, 2026. For fiscal 2025 it was $202.57M, down 2.1% from the year before. Over ten years it grew 49.2% a year on average. The highest annual figure on record is $206.99M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$202.57M-2.1%
FY2024Dec 31, 2024$206.99M+5.5%
FY2023Dec 31, 2023$196.12M+28.9%
FY2022Dec 31, 2022$152.20M+23.5%
FY2021Dec 31, 2021$123.21M+61.2%
FY2020Dec 31, 2020$76.45M+24.2%
FY2019Dec 31, 2019$61.57M-25.8%
FY2018Dec 31, 2018$82.96M+157.6%
FY2017Dec 31, 2017$32.20M+276.1%
FY2016Dec 31, 2016$8.56M+130.3%
FY2015Dec 31, 2015$3.72M+125.0%
FY2014Dec 31, 2014$1.65M0.0%
FY2013Dec 31, 2013$1.65M+1256.2%
FY2012Dec 31, 2012$121.84K-35.9%
FY2011Dec 31, 2011$190.05K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$198.31M-3.5%
Q2 FY2026Jun 30, 2026$197.23M-3.5%
Q1 FY2026Mar 31, 2026$201.19M-3.3%
Q4 FY2025Dec 31, 2025$202.57M-2.1%
Q3 FY2025Sep 30, 2025$205.60M-3.3%
Q2 FY2025Jun 30, 2025$204.37M-2.0%
Q1 FY2025Mar 31, 2025$208.00M+3.3%
Q4 FY2024Dec 31, 2024$206.99M+5.5%
Q3 FY2024Sep 30, 2024$212.68M+11.5%
Q2 FY2024Jun 30, 2024$208.53M+10.1%
Q1 FY2024Mar 31, 2024$201.33M+9.2%
Q4 FY2023Dec 31, 2023$196.12M+28.9%
Q3 FY2023Sep 30, 2023$190.82M+31.9%
Q2 FY2023Jun 30, 2023$189.37M+39.4%
Q1 FY2023Mar 31, 2023$184.39M+34.6%
Q4 FY2022Dec 31, 2022$152.20M+23.5%
Q3 FY2022Sep 30, 2022$144.70M+22.4%
Q2 FY2022Jun 30, 2022$135.88M+51.0%
Q1 FY2022Mar 31, 2022$136.98M+79.2%
Q4 FY2021Dec 31, 2021$123.21M+70.1%
Q3 FY2021Sep 30, 2021$118.24M+74.3%
Q1 FY2021Mar 31, 2021$89.98M+37.7%
Q4 FY2020Dec 31, 2020$76.45M+24.2%
Q3 FY2020Sep 30, 2020$72.45M-47.1%
Q2 FY2020Jun 30, 2020$67.83M-49.3%
Q1 FY2020Mar 31, 2020$65.34M-33.1%
Q4 FY2019Dec 31, 2019$61.57M-25.8%
Q3 FY2019Sep 30, 2019$137.06M+139.9%
Q2 FY2019Jun 30, 2019$133.68M+194.2%
Q1 FY2019Mar 31, 2019$97.63M+187.7%
Q4 FY2018Dec 31, 2018$82.96M+157.6%
Q3 FY2018Sep 30, 2018$57.13M+167.3%
Q2 FY2018Jun 30, 2018$45.44M+196.0%
Q1 FY2018Mar 31, 2018$33.94M+212.8%
Q4 FY2017Dec 31, 2017$32.20M+276.1%
Q3 FY2017Sep 30, 2017$21.37M+177.7%
Q2 FY2017Jun 30, 2017$15.35M–
Q1 FY2017Mar 31, 2017$10.85M–
Q4 FY2016Dec 31, 2016$8.56M–
Q3 FY2016Sep 30, 2016$7.70M–

More MariMed figures

See a number that looks wrong?